AEC-associated p63 mutations lead to alternative splicing/protein stabilization of p63 and modulation of notch signaling

Cell Cycle

Volumn 4, Issue 10, 2005, Pages 1440-1447

  Huang, Yi Ping ^a   Kim, Yuriy ^a   Li, Zhaobo ^a   Fomenkov, Tanya ^a   Fomenkov, Alexey ^a   Ratovitski, Edward A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ABBP1; p63; Proteasome; RACK1; RNA polymerase II; RNA processing; Stratifin

Indexed keywords

KERATINOCYTE GROWTH FACTOR RECEPTOR; MESSENGER RNA; NOTCH RECEPTOR; PROTEASOME; PROTEIN P63;

ALLELE; ALTERNATIVE RNA SPLICING; ANKYLOBLEPHARON ECTODERMAL DYSPLASIA AND CLEFTING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ECTODERMAL DYSPLASIA; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN CELL; KERATINOCYTE; MODULATION; PHENOTYPE; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STABILITY; RNA PROCESSING; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION;

EID: 26444507855     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.10.2086     Document Type: Article

References (37)

1. Yang A, Kaghad M, Wang Y, Gillett E, Fleming M, Dotsch V, Andrews N, Caput D, McKeon F. P63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2:305-16.
2. Mills A, Zheng B, Wang X, Vogel H, Roop D, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398:708-13.
3. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson R, Tabin C, Sharpe A, Caput D, Crum C, McKeon F. P63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398:714-8.
4. Koster M, Kim S, Mills A, DeMayo F, Roop D. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 2004; 18:126-31.
5. Celli J, Duijf P, Hamel B, Bamshad M, Kramer B, Smits A, Newbury-Ecob R, Hennekam R, Van Buggenhout G, van Haeringen A, Woods C, van Essen A, de Waal R, Vriend G, Haber D, Yang A, McKeon F, Brunner H, van Bokhoven H. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999; 99:143-53.
6. McGrath J, Duijf P, Doetsch V, Irvine A, de Waal R, Vanmolkot K, Wessagowit V, Kelly A, Atherton DJ, Griffiths W, Orlow S, van Haeringen A, Ausems M, Yang A, McKeon F, Bamshad M, Brunner H, Hamel B, van Bokhoven H. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum Mol Genet 2001; 10:221-9.
7. Ianakiev P, Kilpatrick M, Toudjarska I, Basel D, Beighton P, Tsipouras P. Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am J Hum Genet 2000; 67:59-66.
8. van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf P, Vanmolkot K, van Beusekom E, van Beersum S, Celli J, Merkx G, Tenconi R, Fryns J, Verloes A, Newbury-Ecob R, Raas-Rotschild A, Majewski F, Beemer F, Janecke A, Chitayat D, Crisponi G, Kayserili H, Yates J, Neri G, Brunner H. p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am J Hum Genet 2001; 69:481-92.
9. Duijf P, Vanmolkot K, Propping P, Friedl W, Krieger E, McKeon F, Dotsch V, Brunner H, van Bokhoven H. Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63. Hum Mol Genet 2002; 11:799-804.
10. Kantaputra P, Hamada T, Kumchai T, McGrath J. Heterozygous mutation in the SAM domain of p63 underlies Rapp-Hodgkin ectodermal dysplasia. J Dent Res 2003; 82:433-7.
11. Ghioni P, Bolognese F, Duijf P, Van Bokhoven H, Mantovani R, Guerrini L. Complex transcriptional effects of p63 isoforms: Identification of novel activation and repression domains. Mol Cell Biol 2002; 22:8659-68.
12. Dohn M, Zhang S, Chen X. P63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 2001; 20:3193-205.
13. Osada M, Yamashita K, Park H, Fomenkov A, Kim M, Wu G, Nomoto S, Trink B, Sidransky D. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol 2005; 25:6077-89.
14. Fomenkov A, Huang Y, Topaloglu O, Brechman A, Osada M, Fomenkov T, Yuriditsky E, Trink B, Sidransky D, Ratovitski E. P63α mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells Syndrome. J Biol Chem 2003; 278:23906-14.
15. Boukamp P, Petrussevska R, Breitkreutz D, Hornung J, Markham A, Fusenig N. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106:761-71.
16. Fomenkov A, Zangen R, Huang Y, Osada M, Guo Z, Fomenkov T, Trink B, Sidransky D, Ratovitski E. RACK1 and stratifin target ΔNp63α for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle 2004; 3:1285-95.
17. Lamartine J. Towards a new classification of ectodermal dysplasias. Clin Exp Dermatol 2003; 28:351-5.
18. Parsa R, Yang A, McKeon F, Green H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999; 113:1099-105.
19. Khan F, Jaiswal A, Szer W. Cloning and sequence analysis of a human type A/B hnRNP protein. FEBS Lett 1991; 290:159-61.
20. Lau P, Zhu H, Nakamuta M, Chan L. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing. J Biol Chem 1997; 272:1452-5.
21. Sarig G, Weisman-Shomer P, Fry M. Telomeric and tetraplex DNA binding properties of qTBP42: A homoloque of the CArG Box binding protein CBF-A. Biochem Biophys Res Comm 1997; 237:617-23.
22. Lau P, Chang B, Chan L. Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a component of apobec-1 editiosome. Biochem. Biophys Res Comm 2001; 282:977-83.
23. Zhou Z, Licklider L, Gygi S, Reed R. Comprehensive proteomic analysis of the human spliceosome. Nature 2002; 419:182-5.
24. Yuryev A, Patturajan M, Litingtung Y, Joshi R, Gentile C, Gebara M, Corden J. The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins. Proc Natl Acad Sci USA 1996; 93:6975-80.
25. Corden J, Patturajan M. CTD function linking transcription to splicing. Trends Biochem Sci 1997; 22:413-6.
26. Proudfoot N, Furger A, Dye M. Integrating mRNA processing with transcription. Cell 2002; 108:501-12.
27. Howe K. RNA polymerase II conducts a symphony of premRNA processing activities. Biochim Biophys Acta 2002; 1577:308-24.
28. Neugebauer K. On the importance of being cotranscriptional. J Cell Sci 2000; 115:3865-71.
29. Okuyama R, Nguyen BC, Talora C, Ogawa E, Tommasi di Vignano A, Lioumi M, Chiorino G, Tagami H, Woo M, Dotto G. High commitment of embryonic keratinocytes to terminal differentiation through a Notch1/caspase 3 regulatory mechanism. Dev Cell 2003; 6:551-62.
30. Sasaki Y, Ishida S, Morimoto I, Yamashita T, Kojima T, Kihara C, Tanaka T, Imai K, Nakamura Y, Tokino T. The p53 family member genes are involved in the Notch signaling pathway. J Biol Chem 2002; 277:719-24.
31. Ross D, Kadesch T. Consequences of Notch-mediated induction of Jagged1. Exp Cell Res 2004; 296:173-82.
32. Drut R, Pollono D, Drut R. Bilateral nephroblastoma in familial Hay-Wells syndrome associated with familial reticulate pigmentation of the skin. Am J Med Genet 2002; 110:164-9.
33. Xue Y, Gao X, Lindsell C, Norton C, Chang B, Hicks C, Gendron-Maguire M, Rand E, Weinmaster G, Gridley T. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 1999; 8:723-30.
34. Krebs L, Xue Y, Norton C, Shutter J, Maguire M, Sundberg J, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith G, Stark K, Gridley T. Notch signaling is essential for vascular morphogenesis in mice. Genes and Dev 2000; 14:1343-52.
35. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, Aster J, Krishna S, Metzger D, Chambon P, Miele L, Aguet M, Radtke F, Dotto G. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 2001; 20:3427-36.
36. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes and Dev 2004; 18:901-11.
37. Nicolas M, Wolfer A, Raj K, Kummer J, Mill P, van Noort M, Hui C, Clevers H, Dotto G, Radtke F. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 2003; 33:416-21.